Table 3.

Mean difference in endogenous thrombin potential between rosuvastatin users and non‐users (reference) at the end of the study, adjusted for coagulation factors

	Mean difference (95% CI)‡
ETP (nm*min) at the end of the study
No coagulation factor	−89.46 (−153.18, −25.74)
+Factor VIII	−87.66 (−148.43, −26.89)
+Factor XI	−73.13 (−133.58, −12.68)
+Factor VII	−59.93 (−120.02, 0.17)
+DD	−87.20 (−151.41, −22.99)
+Factors VIII, XI, VII, DD	−54.98 (−111.99, 2.03)

DD, D dimer; CI, confidence interval. ‡Comparison between rosuvastatin treatment and no treatment at the end of the study, adjusted for age and sex.